Literature DB >> 9575711

Community physicians describe management issues for patients expected to live less than twelve months.

S J Goodlin1, A M Jette, J Lynn, J H Wasson.   

Abstract

We examine management issues experienced by community physicians providing care to patients they expect to die within a year. In a case series, 61 physicians in northern New England enrolled 182 consecutive dying patients. Important management issues for these patients were recorded at enrollment and eight months later. The patients' average age was 74 years; most had cancer (48%) or cardiovascular disease (38%). Almost two-thirds of the patients died within eight months of enrollment. Major management issues for the physicians in care of these patients were deficits in basic self-care, emotional support, pain control, and nutrition. Pain control and family need for support were reported most frequently. Although demand for physician time was seldom a major management issue, when it occurred it correlated with patients' emotional needs or their desire to extend life (p < 0.01). Two barriers to optimum care commonly cited by physicians were (a) the differences in treatment expectations between family members, patients, and physicians and (b) the incurable, progressive nature of the patients' diseases. Efforts to improve care for patients who have limited life expectancy should further explore the perceptions of community physicians.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Professional Patient Relationship

Mesh:

Year:  1998        PMID: 9575711

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  2 in total

Review 1.  The dying patient.

Authors:  J D Cowan
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

2.  The TLC model of palliative care in the elderly: preliminary application in the assisted living setting.

Authors:  Anthony F Jerant; Rahman S Azari; Thomas S Nesbitt; Frederick J Meyers
Journal:  Ann Fam Med       Date:  2004 Jan-Feb       Impact factor: 5.166

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.